Welcome to Progress in Neurology and Psychiatry’s dedicated website. Progress is for health professionals in secondary and primary care looking after patients with neurological and psychiatric diseases. If you are a health professional working in the field of neurology or psychiatry you can register with us for free access to our content.Sign up for e-alerts and print copies

Latest News

More effective MS treatments increase productivity

Disease-modifying therapies (DMTs) for multiple sclerosis (MS) that are most effective are more likely to increase work attendance, work carried out and...Read more

Cannabis effective in childhood epilepsy, review finds

After the recent controversy surrounding the Home Office’s confiscation and subsequent return of medicinal cannabis used to treat a child’s epilepsy...Read more

Schizophrenia mortality still high

Life expectancy is increasing in people with schizophrenia at about the same rate as in the general population but it remains well below what others can...Read more

NHS England helps service users raise concerns

NHS England has published a guide for patients, families and carers of people with a learning disability and autistic people to help them provide feedback,...Read more

Treatment for female hyposexual desire disorder edges closer

Palatin Technologies has applied to the US Food and Drug Administration for marketing approval for melanocortin-receptor-4 agonist bremelanotide for the...Read more

Featured Articles

Neurological sleep medicine: a case note audit from a specialist clinic
In this article, the authors report the findings of an audit of patients with neurological sleep disorders seen in a combined cognitive neurology and sleep disorder clinics over a seven-year period. Also, the results of a pilot of a cognitive behavioural therapy service for insomnia undertaken in the same population are analysed. 
Click here to view

Episodic loss of consciousness: how genetic testing points to diagnosis
The differential diagnosis of episodic loss of consciousness, lying chiefly between syncope and epilepsy, can be challenging and potentially confusing, particularly in the absence of a reliable witness account. We report a patient with episodic loss of consciousness in whom targeted genetic testing contributed to diagnosis. 
Click here to view

‘Z’-hypnotics versus benzodiazepines for the treatment of insomnia
Z-hypnotics have been perceived to be better than benzodiazepines for the treatment of insomnia for many years. NICE guidance focuses on cost effectiveness as there is limited convincing evidence to distinguish between these agents. This review compares Z-drugs and benzodiazepines as hypnotic agents in terms of their efficacy, safety, tolerability and abuse potential.
Click here to view

Web design and marketing agency Leamington Spa